← Leaderboards
Ronald J Mandel
University Of Florida
$3,848,166
Attributed
$4,116,749
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $796.1K · FY2005–12$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$4,116,749 · 5
By mechanism
P01$1,496,819 · 1
R01$1,463,407 · 1
R21$1,156,523 · 3
Top collaborators
- David R Borchelt2 shared
- Jada M Lewis2 shared
Most similar at University Of Florida
Same institution · by research overlap
- Arun Srivastava$10,395,461
- Dongsheng Duan$17,353,422
- David R Borchelt$17,132,004
- Terence R. Flotte$26,412,339
- Christopher A Shaw$1,132,120
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BaseDesignCorpus Striatum StructureRecombinantsProteinsNeurodegenerative DisordersCessation Of LifeDisease ProgressionMediatingMotorMouse ModelAdeno-Associated Viral VectorCellsMutantBehaviorNeuron LossKnock-DownGeneticDisease ModelHuntington DiseaseGenesBrainPathologyResearch Personnel
Grant awards (17)
New Models to Assay Gene Silencing Therapies$183,125
R21 · FY2012 · NS
rAAV-GDNF to study mesolimbic control of body mass$183,125
R21 · FY2012 · NS · contact PI
New Models to Assay Gene Silencing Therapies$219,750
R21 · FY2011 · NS
rAAV-GDNF to study mesolimbic control of body mass$219,750
R21 · FY2011 · NS · contact PI
rAAV-mediated knockdown for Huntington's disease$281,530
R01 · FY2010 · NS · contact PI
rAAV-mediated knockdown for Huntington's disease$284,855
R01 · FY2009 · NS · contact PI
rAAV-mediated knockdown for Huntington's disease$21,383
R01 · FY2009 · NS · contact PI
Glial derived neurotrophic factor for Parkinson's disease$297,913
P01 · FY2008 · NS · contact PI
rAAV-mediated knockdown for Huntington's disease$285,273
R01 · FY2008 · NS · contact PI
Glial derived neurotrophic factor for Parkinson's disease$301,597
P01 · FY2007 · NS · contact PI
rAAV-mediated knockdown for Huntington's disease$285,636
R01 · FY2007 · NS · contact PI
Global spinal cord trophic factor delivery using intracerebral rAAV in ALS rats$156,518
R21 · FY2007 · NS · contact PI
rAAV-mediated knockdown for Huntington's disease$304,730
R01 · FY2006 · NS · contact PI
Glial derived neurotrophic factor for Parkinson's diseas$297,085
P01 · FY2006 · NS · contact PI
Global spinal cord trophic factor delivery using intracerebral rAAV in ALS rats$194,255
R21 · FY2006 · NS · contact PI
Glial derived neurotrophic factor for Parkinson's diseas$294,272
P01 · FY2005 · NS
Glial derived neurotrophic factor for Parkinson's diseas$305,952
P01 · FY2004 · NS